Centessa CNTA Stock Investment Risks Quiet 20260427 PFSI PennyMac stock rises 171 percent despite Q4 2025 EPS landing 40 percent below analyst forecasts Is Core Sci CORZ stock weakening further Q4 2025 Better Than Expected Rhythm Pharmaceuticals RYTM Stock Trend Direction Analysis Q4 2025 Profit Exceeds Views RVMD Revolution Medicines edges higher after reporting wider than expected Q4 2025 per share loss